Internal Medicine, Hematology · Philadelphia, PA
NPI
1457414625
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Civic Center Blvd.
Philadelphia, PA, 19104
Phone (215) 615-5858
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
272 services
Medicare patients, 2024
192
Average age 70
Drug cost, 2024
$1.4M
532 prescriptions
Company payments, 2025
$10K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam Cuker was code 99214 (office e&m - established), 80 times for 76 patients. In total Adam Cuker billed 272 services in 15 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 80 | 76 | $73.49 | $5,879 |
| 85390 Test - Miscellaneous | Facility | 74 | 73 | $28.64 | $2,120 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 53 | 52 | $12.82 | $680 |
| 99205 Office E&M - New | Facility | 18 | 18 | $142.26 | $2,561 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $105.80 | $1,375 |
By year: 2022 $12K for 183 services; 2023 $13K for 191 services; 2024 $15K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam Cuker prescribed most often to Medicare patients was Eliquis (Apixaban), with 157 prescriptions and refills. In total Adam Cuker wrote 532 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 157 | 278 | 31 | $159K |
| Xarelto Rivaroxaban | 80 | 160 | 18 | $95K |
| Hydroxyurea Generic | 33 | 69 | Under 11 | $685 |
| Enoxaparin Sodium Generic | 27 | 29 | Under 11 | $9,658 |
| Morphine Sulfate Er Morphine Sulfate | 25 | 25 | Under 11 | $629 |
| Fondaparinux Sodium Generic | 24 | 24 | Under 11 | $40K |
| Morphine Sulfate Generic | 22 | 22 | Under 11 | $719 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 18 | 18 | Under 11 | $124 |
| Nplate Romiplostim | 17 | 17 | Under 11 | $551K |
| Fragmin Dalteparin Sodium,porcine | 15 | 15 | Under 11 | $39K |
| Soliris Eculizumab | 14 | 14 | Under 11 | $365K |
| Celecoxib Generic | 13 | 19 | Under 11 | $1,184 |
| Zolpidem Tartrate Generic | 12 | 12 | Under 11 | $62.87 |
| Diphenhydramine Hcl Generic | 11 | 11 | Under 11 | $12.87 |
Brand drugs: 325 claims; generic drugs: 207 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam Cuker $10K ($564 in general payments such as food, travel and fees and $9,809 for research) from 6 companies. The largest payer was Pfizer Inc. with $8,170.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.